RANI COOPER: Open Payments
NPI 1285839084 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 71 payments from 12 companies in 2025. Trend: 2023 $1,167 · 2024 $1,088 · 2025 $1,034
Food & beverage: $939Education: $95
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $235 |
| Janssen Biotech, Inc. | 6 | $178 |
| ABBVIE INC. | 12 | $162 |
| Arcutis Biotherapeutics, Inc. | 20 | $146 |
| REVANCE THERAPEUTICS, INC. | 1 | $65 |
| PFIZER INC. | 3 | $61 |
| LEO Pharma Inc. | 2 | $47 |
| Galderma Laboratories, L.P. | 2 | $34 |
| Botanix SB Inc | 2 | $32 |
| Incyte Corporation | 1 | $30 |
Products named: COSENTYX, TREMFYA, Zoryve, SKYRIZI, DAXXIFY, CIBINQO, RINVOQ, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
